Assessment of Hydroxyethyl Starch (6% HES 130/0.4) Kidney Storage in Critically Ill Dogs: A Post-mortem Prospective Study

被引:1
|
作者
Adamik, Katja-Nicole [1 ]
Stoffel, Michael H. [2 ]
Tangermann, Simone [3 ]
de Breuyn Dietler, Bettina [4 ]
Stokar-Regenscheit, Nadine [2 ]
机构
[1] Univ Bern, Dept Vet Clin Med, Div Small Anim Emergency & Crit Care, Bern, Switzerland
[2] Univ Bern, Dept Clin Res & Vet Publ Hlth, Div Vet Anat, Bern, Switzerland
[3] Univ Bern, Inst Anim Pathol Vetsuisse Fac, Dept Infect Dis & Pathobiol, Bern, Switzerland
[4] Univ Bern, Inst Anat, Div Topog & Clin Anat, Bern, Switzerland
关键词
synthetic colloids; AKI; osmotic nephrosis; tetrastarch; fluid therapy; OSMOTIC-NEPHROSIS; CREATININE CONCENTRATION; MOLECULAR-WEIGHT; INJURY; RESUSCITATION; PHARMACOKINETICS; ACCUMULATION; PATIENT; SEPSIS; PLASMA;
D O I
10.3389/fvets.2021.802507
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
Objective: Intravenous hydroxyethyl starch (HES) solutions are potentially nephrotoxic due to rapid renal tissue uptake, subsequent osmotic nephrosis, and long-lasting intracellular storage. This study aimed to investigate the severity of intracellular storage of HES in renal tissue samples from critically ill dogs receiving 6% HES 130/0.4.Materials and Methods: Fresh, post-mortem (<2 h after death) renal tissue samples were analyzed through histology, immunohistochemistry (HES 130/0.4-specific antibodies), and electron microscopy for the severity of renal tubular vacuolization (VAC), intravacuolar HES accumulation (ACC), and ultra-structure impairment. Moreover, we investigated the relationship between VAC or ACC grade and HES dose (mL/kg), duration of HES administration (h), and pre-HES plasma creatinine concentrations.Results: Histology revealed that 2/20 dogs (10%) had no, 11/20 dogs (55%) had mild, 5/20 dogs (25%) had moderate, and 2/20 dogs (10%) had severe VAC. Immunohistochemistry revealed that 5/20 dogs (25%) had no, 6/20 dogs (30%) had mild, 7/20 dogs (35%) had moderate, and 2/20 dogs (10%) had severe ACC. Both changes were predominantly found in the distal tubular epithelium of mild and moderate cases, and all tubular segments were affected in severe cases. Seven of 20 dogs (35%) had osmotic nephrosis (ON). On electron microscopy, large granules with an electron-dense content were repeatedly detected in individual cells, mainly in the distal tubules. No correlation was found between cumulative HES dose or duration of HES administration and VAC grade, ACC grade, or presence/absence of ON.Conclusion: A high percentage of dogs had renal tubular HES storage and one-third of dogs showed HES-induced ON. Short-term HES administration caused VAC and ACC, regardless of the dose or duration of administration. In contrast to previous studies, HES 130/0.4 deposits were mainly located in the renal distal tubule.
引用
收藏
页数:10
相关论文
共 50 条
  • [31] 6% Hydroxyethyl starch (HES 130/0.4) diminishes glycocalyx degradation and decreases vascular permeability during systemic and pulmonary inflammation in mice
    Margraf, Andreas
    Herter, Jan M.
    Kuehne, Katharina
    Stadtmann, Anika
    Ermert, Thomas
    Wenk, Manuel
    Meersch, Melanie
    Van Aken, Hugo
    Zarbock, Alexander
    Rossaint, Jan
    [J]. CRITICAL CARE, 2018, 22
  • [32] Biomarkers of Coagulation and Inflammation in Dogs after Randomized Administration of 6% Hydroxyethyl Starch 130/0.4 or Hartmann's Solution
    Boyd, Corrin J.
    Raisis, Anthea L.
    Sharp, Claire R.
    Claus, Melissa A.
    Hosgood, Giselle
    Smart, Lisa
    [J]. ANIMALS, 2022, 12 (19):
  • [33] The effect of haemodilution with 6% hydroxyethyl starch (130/0.4) on haemostasis in pregnancy: an in-vitro assessment using thromboelastometry
    Ansari, Tarek
    Riad, Waleed
    [J]. EUROPEAN JOURNAL OF ANAESTHESIOLOGY, 2010, 27 (03) : 304 - 305
  • [34] THE EFFECT OF 6% HES (HYDROXYETHYL STARCH) 130/0.4 ON THE CONCENTRATION OF BLOOD POTASSIUM IN ORTHOPEDIC AHD (ACUTE HEMODIULUTION) PATIENTS AND ITS MECHANISM EXPLORATION
    Zhang, Jianzhong
    Dong, Chuanzhen
    Huang, Shaoyan
    Shao, Wei
    Ma, Huashan
    Yan, Yurong
    [J]. ACTA MEDICA MEDITERRANEA, 2020, 36 (02): : 989 - 994
  • [35] The effects of tranexamic acid and 6% hydroxyethyl starch (HES) solution (130/0.4) on postoperative bleeding in coronary artery bypass graft (CABG) surgery
    Yanartas, M.
    Baysal, A.
    Aydin, C.
    Ay, Y.
    Kara, I.
    Aydin, E.
    Cevirme, D.
    Koksal, C.
    Sunar, H.
    [J]. INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2015, 8 (04): : 5959 - 5971
  • [36] Effects of the novel 6% hydroxyethyl starch 130/0.4 on renal function of recipients in living-related kidney transplantation
    Wu Yan
    Wu An-shi
    Wang Jun
    Tian Ming
    Jia Xin-yuan
    Rui Yan
    Yue Yun
    [J]. CHINESE MEDICAL JOURNAL, 2010, 123 (21) : 3079 - 3083
  • [37] 0.9 % Saline vs 6 % HES 130/0.4 for fluid resuscitation in critically ill patients (vol 8, pg 347, 2013)
    Nenna, Giulia
    Costantino, Giorgio
    [J]. INTERNAL AND EMERGENCY MEDICINE, 2013, 8 (07) : 643 - 643
  • [38] Fluid Resuscitation with 6% Hydroxyethyl Starch (130/0.4) in Acutely Ill Patients: An Updated Systematic Review and Meta-Analysis
    Gattas, David J.
    Dan, Arina
    Myburgh, John
    Billot, Laurent
    Lo, Serigne
    Finfer, Simon
    [J]. ANESTHESIA AND ANALGESIA, 2012, 114 (01): : 159 - 169
  • [39] EVALUATION OF THE RISK OF ACUTE KIDNEY INJURY ASSOCIATED WITH THE USE OF HYDROXYETHYL STARCH 130/0.4 (VOLUVEN 6%) IN CARDIAC SURGERY
    Frenette, A. J.
    Bernier, P.
    Charbonneau, A.
    Nguyen, L. T.
    Troyanov, S.
    Rioux, J. P.
    Heylbroeck, C.
    Williamson, D.
    [J]. INTENSIVE CARE MEDICINE, 2011, 37 : S255 - S255
  • [40] Effect of 6% hydroxyethyl starch 130/0.4 on kidney and haemostatic function in cardiac surgical patients: a randomised controlled trial
    Duncan, A. E.
    Jia, Y.
    Soltesz, E.
    Leung, S.
    Yilmaz, H. O.
    Mao, G.
    Timur, A. A.
    Kottke-Marchant, K.
    Rogers, H. J.
    Ma, C.
    Ince, I.
    Karimi, N.
    Yagar, S.
    Trombetta, C.
    Sessler, D., I
    [J]. ANAESTHESIA, 2020, 75 (09) : 1180 - 1190